FasterCures, a non-profit think tank with the goal of speeding and improving the medical research system, recently debuted a new resource to track implementation of the 21st Century Cures Act.
About Stephanie Fischer
This author has yet to write their bio.
Meanwhile lets just say that we are proud Stephanie Fischer contributed a whooping 17 entries.
PDUFA enables FDA to collect user fees from biopharmaceutical companies in order to enable the Agency to review the safety and efficacy of new medicines more quickly. It is important for PDUFA to be reauthorized by the end of July or FDA will not be able to accept the user fees and would need to send furlough notices to staff.
More than 600 rare disease patients, caregivers, researchers and other advocates joined us during Rare Disease Week on Capitol Hill in Washington, DC from Monday, February 27th, through Thursday, March 2nd.
There are a few things you can do to prepare to ensure a productive experience at Rare Disease Week at Capitol Hill and minimize last-minute stress.
On January 24th at 3pm EST, the National Organization for Rare Disorders (NORD) will host a webinar on the 2016 State Report Card. Tim Boyd, Associate Director of State Policy at NORD, will discuss the report card and discuss what this means for 2017 advocacy initiatives across the country. There will be an opportunity to ask questions. […]
As we noted in a news brief last month, the law firm of Hyman, Phelps & McNamara P.C. has featured several blogposts on different provisions of 21st Century Cures Act. They will host two free webinars this month to further examine the Act, which will be good opportunities for advocates to learn more and ask […]
Join fellow rare disease patients, caregivers and other advocates from across the country at Rare Disease Week on Capitol Hill from February 27th through March 2nd, 2017. This is an opportunity for YOU to help educate the new Congress and shape healthcare policy to better meet the needs of the rare disease community. All of […]